A pragmatic and commercial driven leader with over 20 years’ experience in the healthcare sector including medical device commercialisation, pharmaceutical and in vitro diagnostics industries across domestic and international markets. For the past ~2 years, Glenn has been consulting to various domestic and international medical device and pharmaceutical companies. Prior to this, Glenn was CEO/MD at Rhythm Biosciences (ASX: RHY) and held leadership roles at Medical Developments International (ASX: MVP) and CSL (ASX: CSL). He has extensive business experience across the UK, Europe, Asia, North and South America. Glenn holds a Master of Business Administration (MBA), Graduate Certificate in Corporate Management and a Bachelor of Science degree.